Physician profile
Ronald E Kope
NPI 1326463407
$1,707.41
in general payments reported to CMS, 2019-2025
17 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.83 · 2023: $1,217 · 2024: $184 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089 · Travel and Lodging: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.43 |
| Travel and Lodging | $537.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,094.72 | 2022-2023 | Mycarelink |
| Boston Scientific Corporation | $186.22 | 2022-2025 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.71 | 2023-2024 | Lifevest |
| Novo Nordisk INC | $59.90 | 2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $40.52 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $39.79 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $25.49 | 2024 | Gemtesa |
| Bioventus LLC | $24.01 | 2025 | Gelsyn-3 |
| Astrazeneca Pharmaceuticals Lp | $23.34 | 2024 | Farxiga |
| Avanos Medical | $23.23 | 2024 | Genvisc 850 Sodium Hyaluronate |
| Convatec INC. | $15.63 | 2024 | |
| Fidia Pharma USA INC. | $14.98 | 2025 | Hymovis, Triluron |
| Irhythm Technologies, INC. | $14.66 | 2023 | Zio Xt Patch |
| Amgen INC. | $13.90 | 2025 | Krystexxa |
| Baxter Healthcare | $13.06 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12.45 | 2022 | |
| Abbvie INC. | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Kope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.